At this time, posts about Isu Abxis are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 13,282 shares today. Isu Abxis is known as a subsidiary of the Isu Group, developing antibiotic treatments and providing medical services.
As of 1:30 PM on the 25th, Isu Abxis's stock price is 8,220 KRW, down 0.12% from the previous day, with a trading volume of 1,526,207 shares, which is about 21.93% of the 5-day average trading volume. On February 23, Isu Abxis was a market issue with the "rising trend due to agreement on producing Russian COVID-19 vaccine."
In addition to Isu Abxis, posts by investors are also rapidly increasing for Naivec (138610), Neontech (306620), and Genie Music (043610).
※Source: AI Investment Assistant AI Rassiro
※ This article was written in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
